Thelansis

  Chemotherapy-induced diarrhea (CID) poses a prevalent challenge, particularly among patients who have advanced cancer. Possible risk factors for CID include the existence of a primary tumor, a previous history of CID, and the administration of chemotherapy during the summer months.CID may be classified as uncomplicated (graded 1–2 with no complicating factors) to complicated (graded 3–4 with one or more complicating signs or symptoms). CID condition can also exhibit early onset (occurring within 24 hours of administration) or late onset (manifesting more than 24 hours post-administration), and it may persist (lasting over four weeks) or resolve relatively quickly (subsiding within four weeks) by the National Cancer Institute’s Common Terminology Criteria for Adverse Effects grading system. Conventional initial treatments for CID typically involve the use of opioids such as loperamide and diphenoxylate. The severity of diarrhea is such that it may necessitate dose adju...